News & Events about Gritstone Oncology Inc.
2 months ago
Matthew Hawryluk, Ph.D.
POAI Board of Directors
EAGAN, Minn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Matthew J. Hawryluk, Ph.D., (www.predictive-oncology.com) to its Board of Directors to help support the companys ...
3 months ago
-- Median overall survival (OS) for patients with metastatic, microsatellite stable colorectal cancer (MSS-CRC) who had two prior lines of therapy and had molecular response will now exceed 22 months median not yet reached -- -- Patients who achieve a molecular response include those with liver ...
7 months ago
EMERYVILLE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the worlds most potent vaccines, today announced that the companys Board of Directors has granted eight employees nonqualified stock options to ...
8 months ago
-- Results, which were previously pre-printed in bioRxiv, show Gritstones second-generation self-amplifying mRNA (samRNA) vaccine candidate drove broad neutralizing antibodies, T cell responses and offered protection against SARS-CoV-2 infection in rhesus macaques -- -- Neutralizing antibody ...
8 months ago
EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the worlds most potent vaccines, today announced that the company has been certified as a Great Place to Work by the Great Place to Work Institute. ...